Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.13 (
protein kinase C
)
49,245
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Jatrophone
, staurosporine and H-7, caused graded inhibition of rat portal vein contractions induced by phorbol 12-myristate 13-acetate (PMA), noradrenaline, endothelin-1 or KCl, with IC50s of 86 nM, 13 microM, 11 microM and 9 microM, respectively.
Jatrophone
was equipotent to H-7, but 100 to 500 fold less potent than staurosporine.
Jatrophone
, H-7 and staurosporine, also dose-dependently inhibited rhythmic contractions of the rat portal-mesenteric vein with IC50s of 15 microM, 9 microM and 75 nM, respectively.
Jatrophone
, H-7 and staurosporine caused graded relaxations of preparations contracted with endothelin-1 or PMA with IC50s of 12 and > 1000 microM, 8 and 13 microM and 7 and 12 nM, respectively. All three compounds caused graded inhibition of caffeine-induced contractions in Ca(2+)-free solution containing EGTA. The similarity between the vasorelaxant actions of jatrophone, staurosporine and H-7 in rat portal vein suggests that jatrophone acts, at least in part, through inhibition of
PKC
-dependent mechanisms. Moreover, like the
PKC
inhibitors, its vasorelaxant action may also involve other mechanisms unrelated to
protein kinase C
inhibition.
...
PMID:The relaxant action of jatrophone in rat portal vein. A comparison with protein kinase C inhibitors. 763 Mar 15
We have recently reported that the diterpene jatrophone antagonizes the effects of phorbol ester in pharmacogical studies. In order to investigate further whether this action is associated with an inhibition of
protein kinase C
activity, we examined the effect of jatrophone on the stimulation of lymphocyte activities which are dependent on the
protein kinase C
pathway.
Jatrophone
(0.02-0.32 microM) caused concentration-dependent and equipotent inhibition of human lymphocyte proliferation induced by 5 micrograms/ml of phytohemagglutinin or by a combination of 100 ng/ml of 12-O-tetradecanoyl phorbol-13-acetate (TPA) plus 0.15 microM ionomicyn, with IC50 values (and their 95% confidence limits) of 53.4 (42.6-65.3) nM and 48.4 (39.4-59.8) nM, respectively.
Jatrophone
also blocked, in a concentration-dependent fashion, the murine lymphocyte proliferation stimulated by 5 micrograms/ml of concanavalin A, with an IC50 value of 63.5 (51.2-76.5) nM. The inhibition was not due to a toxic effect as the pre-incubation of lymphocytes for 48 h with 0.32 microM jatrophone did not impair the proliferation after removal of the diterpene from the culture medium. Human lymphocytes when pre-treated with 10 ng/ml TPA had a 3 times higher spontaneous natural killer activity against K562 cells and an increased expression of CD69. In addition, jatrophone inhibited both spontaneous and TPA-stimulated natural killer activity and the expression of CD69.
Jatrophone
concentrations that inhibited 75% of lymphocyte proliferation did not impair the intracellular increase in Ca2+ flux in lymphocytes stimulated by phytohemagglutinin. These results indicate that jatrophone is a potent inhibitor of activation of lymphocytes, probably through inhibition of the
protein kinase C
pathway.
...
PMID:Jatrophone and 12-O-tetradecanoyl phorbol-13-acetate antagonism of stimulation of natural killer activity and lymphocyte proliferation. 889 16